Publications and IP

We develop and commercialize innovative treatments for with severe and life-threatening conditions. Our products have the potential to improve outcomes for groundbreaking regenerative cell therapies and in the treatment of neurological and opthalmic disease. They give hope where existing drugs have failed and there are no satisfactory alternatives.

Bild poster ILB
Bild poster ILB
Download JPG

IP Comprehensive product protection

We understand the importance of protecting our development products and ILB is covered by multiple composition and specific-use patents.

Patents

Title

Approved countries

New dextran sulfate
Approved countries:
Induce angiogenesis
Approved countries:
Treatment of fibrosis
Approved countries:
Treatment of neurological diseases, disorders, and damages
Approved countries:
Treatment of glaucoma
Approved countries: